Brixadi
Payments companies reported to CMS as associated with Brixadi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Brixadi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Brixadi
These are the largest totals companies reported as associated with Brixadi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Deyhimy | Laguna Hills, CA | Anesthesiology | $280,818.38 |
| John Rocco Rodney | Memphis, TN | Addiction Medicine (Family Medicine) | $251,038.57 |
| Michael Frost | Ambler, PA | Internal Medicine | $226,901.67 |
| James Lim | Irwin, PA | Family Medicine | $186,799.06 |
| Parag Patel | Cincinnati, OH | Addiction Medicine (Internal Medicine) | $169,794.60 |
| Dennis Langer | Naples, FL | Psychiatry | $165,000.00 |
| Ximena Sanchez-Samper | Boston, MA | Psychiatry | $130,096.17 |
| Edmond Hakimi | Calverton, NY | Addiction Medicine (Internal Medicine) | $125,388.59 |
| Kent Hoffman | Maitland, FL | Family Medicine | $118,984.87 |
| Elizabeth Drew | Doylestown, PA | Family Medicine | $81,996.44 |
Prescribed Brixadi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.